Dexcom wins CE Mark for latest continuous glucose monitor

Dexcom (NSDQ:DXCM) won CE Mark clearance today in the European Union for its G6 continuous glucose monitoring system.

The G6 system, which won approval in the U.S. as ‘fully interoperable’ with other medical devices, includes a redesigned applicator that inserts a small sensor below the user’s skin. The sensor measures glucose levels and sends the data to a display device via a transmitter, which can be worn for up to 10 days.

Get the full story at our sister site, Drug Delivery Business News.

The post Dexcom wins CE Mark for latest continuous glucose monitor appeared first on MassDevice.

from MassDevice https://ift.tt/2sSqHfj